Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer
- PMID: 24985972
- DOI: 10.1007/s11033-014-3491-0
Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer
Abstract
Complex molecular changes that occur during prostate cancer (PCa) progression have been described recently. Whole genome sequencing of primary PCa samples has identified recurrent gene deletions and rearrangements in PCa. Specifically, these molecular events disrupt the gene loci of phosphatase and tensin homolog (PTEN) and membrane-associated guanylate kinase inverted-2 (MAGI2). In the present study, we analyzed the expression profile of MAGI2 gene in a cohort of clinical PCa (n = 45) and benign prostatic hyperplasia (BPH) samples (n = 36) as well as three PCa cell lines. We also studied the expression of PCa-related genes, including PTEN, NKX3.1, SPINK1, DD3, AMACR, ERG, and TMPRSS2-ERG fusion in the same samples. The expression of MAGI2 mRNA was significantly down-regulated in PC3, LNCaP and DU-145 PCa cell lines (p = 0.000), and also in clinical tumor samples (Relative expression = 0.307, p = 0.002, [95 % CI 0.002-12.08]). The expression of PTEN, NKX3.1, SPINK1, DD3, and AMACR genes was significantly deregulated in prostate tumor samples (p range 0.000-0.044). A significant correlation was observed between MAGI2 and NKX3.1 expression in tumor samples (p = 0.006). Furthermore, the inclusion of MAGI2 in the gene panel improved the accuracy for discrimination between PCa and BPH samples with the sensitivity and specificity of 0.88 [CI 0.76-0.95] and 0.83 [CI 0.68-0.92], respectively. The data presented here suggest that MAGI2 gene can be considered as a novel component of gene signatures for the detection of PCa.
Similar articles
-
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.J Clin Oncol. 2015 Sep 1;33(25):2789-96. doi: 10.1200/JCO.2014.59.8912. Epub 2015 Jul 20. J Clin Oncol. 2015. PMID: 26195723 Free PMC article.
-
Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23. Prostate. 2015. PMID: 25809148 Free PMC article.
-
Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.Histopathology. 2012 Mar;60(4):645-52. doi: 10.1111/j.1365-2559.2011.04116.x. Epub 2012 Jan 19. Histopathology. 2012. PMID: 22260502
-
Prostate cancer SubtyPINg biomarKers and outcome: is clarity emERGing?Clin Cancer Res. 2014 Sep 15;20(18):4733-6. doi: 10.1158/1078-0432.CCR-14-0818. Epub 2014 Jun 18. Clin Cancer Res. 2014. PMID: 24944315 Free PMC article. Review.
-
The Genetic Complexity of Prostate Cancer.Genes (Basel). 2020 Nov 25;11(12):1396. doi: 10.3390/genes11121396. Genes (Basel). 2020. PMID: 33255593 Free PMC article. Review.
Cited by
-
Inactivation of RB1, CDKN2A, and TP53 have distinct effects on genomic stability at side-by-side comparison in karyotypically normal cells.Genes Chromosomes Cancer. 2023 Feb;62(2):93-100. doi: 10.1002/gcc.23096. Epub 2022 Sep 30. Genes Chromosomes Cancer. 2023. PMID: 36124964 Free PMC article.
-
The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer.Clin Epigenetics. 2022 Jan 6;14(1):4. doi: 10.1186/s13148-021-01224-0. Clin Epigenetics. 2022. PMID: 34991696 Free PMC article.
-
A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer.Cancers (Basel). 2021 Aug 24;13(17):4264. doi: 10.3390/cancers13174264. Cancers (Basel). 2021. PMID: 34503076 Free PMC article. Review.
-
MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions.Cells. 2021 Jun 14;10(6):1494. doi: 10.3390/cells10061494. Cells. 2021. PMID: 34198584 Free PMC article. Review.
-
HIST1H2BB and MAGI2 Methylation and Somatic Mutations as Precision Medicine Biomarkers for Diagnosis and Prognosis of High-grade Serous Ovarian Cancer.Cancer Prev Res (Phila). 2020 Sep;13(9):783-794. doi: 10.1158/1940-6207.CAPR-19-0412. Epub 2020 Jun 24. Cancer Prev Res (Phila). 2020. PMID: 32581010 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials